RESMED INC — Director's Dealing 2019

May 7, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2019-05-03

Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-05-03	ResMed Common Stock	M	4367	$52.02	Acquired	122579	Direct
2019-05-03	ResMed Common Stock	S	4367	$112.58	Disposed	118122	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-05-03	ResMed Common Stock Options	$52.02	M	4367	Disposed	2021-11-19	ResMed Commmon Stock (4367)	Direct

Footnotes

F1: The transaction was conducted under a Rule 10b5-1 plan.

F2: Includes 119.99 shares of ResMed stock purchased on April 30, 2019, through the ResMed Employee Stock Purchase Plan.

F3: Represents date options first became exercisable. Options vest 1/3 per year.